\documentclass[10pt,a4paper]{article}

% Packages
\usepackage{fancyhdr}           % For header and footer
\usepackage{multicol}           % Allows multicols in tables
\usepackage{tabularx}           % Intelligent column widths
\usepackage{tabulary}           % Used in header and footer
\usepackage{hhline}             % Border under tables
\usepackage{graphicx}           % For images
\usepackage{xcolor}             % For hex colours
%\usepackage[utf8x]{inputenc}    % For unicode character support
\usepackage[T1]{fontenc}        % Without this we get weird character replacements
\usepackage{colortbl}           % For coloured tables
\usepackage{setspace}           % For line height
\usepackage{lastpage}           % Needed for total page number
\usepackage{seqsplit}           % Splits long words.
%\usepackage{opensans}          % Can't make this work so far. Shame. Would be lovely.
\usepackage[normalem]{ulem}     % For underlining links
% Most of the following are not required for the majority
% of cheat sheets but are needed for some symbol support.
\usepackage{amsmath}            % Symbols
\usepackage{MnSymbol}           % Symbols
\usepackage{wasysym}            % Symbols
%\usepackage[english,german,french,spanish,italian]{babel}              % Languages

% Document Info
\author{doramarin}
\pdfinfo{
  /Title (taugasjukdomar-barna.pdf)
  /Creator (Cheatography)
  /Author (doramarin)
  /Subject (Taugasjúkdómar barna Cheat Sheet)
}

% Lengths and widths
\addtolength{\textwidth}{6cm}
\addtolength{\textheight}{-1cm}
\addtolength{\hoffset}{-3cm}
\addtolength{\voffset}{-2cm}
\setlength{\tabcolsep}{0.2cm} % Space between columns
\setlength{\headsep}{-12pt} % Reduce space between header and content
\setlength{\headheight}{85pt} % If less, LaTeX automatically increases it
\renewcommand{\footrulewidth}{0pt} % Remove footer line
\renewcommand{\headrulewidth}{0pt} % Remove header line
\renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit
% This two commands together give roughly
% the right line height in the tables
\renewcommand{\arraystretch}{1.3}
\onehalfspacing

% Commands
\newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour
\newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols
\newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns
\newcommand{\tn}{\tabularnewline} % Required as custom column type in use

% Font and Colours
\definecolor{HeadBackground}{HTML}{333333}
\definecolor{FootBackground}{HTML}{666666}
\definecolor{TextColor}{HTML}{333333}
\definecolor{DarkBackground}{HTML}{31A3A3}
\definecolor{LightBackground}{HTML}{F2F9F9}
\renewcommand{\familydefault}{\sfdefault}
\color{TextColor}

% Header and Footer
\pagestyle{fancy}
\fancyhead{} % Set header to blank
\fancyfoot{} % Set footer to blank
\fancyhead[L]{
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{C}
    \SetRowColor{DarkBackground}
    \vspace{-7pt}
    {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent
        \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}}
    }
\end{tabulary}
\columnbreak
\begin{tabulary}{11cm}{L}
    \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Taugasjúkdómar barna Cheat Sheet}}}} \\
    \normalsize{by \textcolor{DarkBackground}{doramarin} via \textcolor{DarkBackground}{\uline{cheatography.com/162386/cs/40816/}}}
\end{tabulary}
\end{multicols}}

\fancyfoot[L]{ \footnotesize
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{LL}
  \SetRowColor{FootBackground}
  \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}}  \\
  \vspace{-2pt}doramarin \\
  \uline{cheatography.com/doramarin} \\
  \end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}}  \\
   \vspace{-2pt}Not Yet Published.\\
   Updated 15th October, 2023.\\
   Page {\thepage} of \pageref{LastPage}.
\end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}}  \\
  \SetRowColor{white}
  \vspace{-5pt}
  %\includegraphics[width=48px,height=48px]{dave.jpeg}
  Measure your website readability!\\
  www.readability-score.com
\end{tabulary}
\end{multicols}}




\begin{document}
\raggedright
\raggedcolumns

% Set font size to small. Switch to any value
% from this page to resize cheat sheet text:
% www.emerson.emory.edu/services/latex/latex_169.html
\footnotesize % Small font.

\begin{multicols*}{3}

\begin{tabularx}{5.377cm}{x{2.14011 cm} x{2.83689 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Taugasjúkdómar barna}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{H{\"o}fuðverkir}} \{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
{\bf{Frumkominn eða afleiddur}} & Primary \& second \tn 
% Row Count 3 (+ 2)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Rauð fl{\"o}gg}}} \tn 
% Row Count 4 (+ 1)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Yngra en 7 ára} \tn 
% Row Count 5 (+ 1)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Merki um aukin innankúbuþrýsting} \tn 
% Row Count 6 (+ 1)
% Row 5
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Staðbundin taugaeinkenni} \tn 
% Row Count 7 (+ 1)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Einkenni hausverks} \tn 
% Row Count 8 (+ 1)
% Row 7
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Skyndilega mikill hausverkur, hausverkur, vaxandi tíðni og alvarleiki, skert meðvitund}}} \tn 
% Row Count 10 (+ 2)
% Row 8
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Aukið h{\"o}fuðrúmmál barns} \tn 
% Row Count 11 (+ 1)
% Row 9
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{\{\{ac\}\}{\bf{Birtingarmynd mígrenis í b{\"o}rnum}}} \tn 
% Row Count 12 (+ 1)
% Row 10
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{10\% unglinga eru með mígreni\{\{ac\}\}} \tn 
% Row Count 13 (+ 1)
% Row 11
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{severe, debilitating headaches that can last hours or days and are often accompanied with pain, nausea, vomiting, sensitivity to light and sound, and dizziness}}} \tn 
% Row Count 17 (+ 4)
% Row 12
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Meðferð mígrenis hjá b{\"o}rnum}}} \tn 
% Row Count 18 (+ 1)
% Row 13
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Þekking} \tn 
% Row Count 19 (+ 1)
% Row 14
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Væntingar} \tn 
% Row Count 20 (+ 1)
% Row 15
\SetRowColor{white}
Viðbr{\"o}gð við kasti & {\emph{Rescue treatments}} \tn 
% Row Count 22 (+ 2)
% Row 16
\SetRowColor{LightBackground}
Meðferð í kasti & {\emph{Fyrirbyggjandi treatments}} \tn 
% Row Count 24 (+ 2)
% Row 17
\SetRowColor{white}
Fyrirbyggjandi meðferð & {\emph{Psycosocial support}} \tn 
% Row Count 26 (+ 2)
% Row 18
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{1.Rescue treatments}}} \tn 
% Row Count 27 (+ 1)
% Row 19
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Analgesia Antimetics Triptans Physical treatments}}} \tn 
% Row Count 29 (+ 2)
% Row 20
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{2.Fyrirbyggjandi treatments}}} \tn 
% Row Count 30 (+ 1)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.14011 cm} x{2.83689 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Taugasjúkdómar barna (cont)}}  \tn
% Row 21
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Sodium channel blockers, beta blockers, triclycs} \tn 
% Row Count 1 (+ 1)
% Row 22
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{3. Psycosocial support}}} \tn 
% Row Count 2 (+ 1)
% Row 23
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Krampar}}\{\{ac\}\}} \tn 
% Row Count 3 (+ 1)
% Row 24
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Kippir og k{\"o}st eru algeng hjá b{\"o}rnum á {\"o}llum aldri Hjá yngstu b{\"o}rnum margvíslegir eðlilegir kippir, hjá þeim elstu algeng starfrænir kippir og kækir}}} \tn 
% Row Count 7 (+ 4)
% Row 25
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Orsakir}}} \tn 
% Row Count 8 (+ 1)
% Row 26
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Alls konar kippir, heilablóðfall, hitakrampar} \tn 
% Row Count 9 (+ 1)
% Row 27
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Kækir, flog} \tn 
% Row Count 10 (+ 1)
% Row 28
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{H{\"o}fuðáverkar,yfirlið, eiturlyf, starfrænir kippir} \tn 
% Row Count 12 (+ 2)
% Row 29
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Hitakrampar}}\{\{ac\}\}} \tn 
% Row Count 13 (+ 1)
% Row 30
\SetRowColor{white}
{\bf{Aldur}} & 3 mánaða – 6 ára \tn 
% Row Count 14 (+ 1)
% Row 31
\SetRowColor{LightBackground}
{\bf{T{\"o}lfræði}} & 5 \% barna, meira í sumum fj{\"o}lskyldum \tn 
% Row Count 16 (+ 2)
% Row 32
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Þriðja hvert barn sem hefur fengið hitakrampa fær aftur hitakrampa seinna} \tn 
% Row Count 18 (+ 2)
% Row 33
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Meðferð}}} \tn 
% Row Count 19 (+ 1)
% Row 34
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Þarf skoðun hjá lækni í fyrsta skiptið} \tn 
% Row Count 20 (+ 1)
% Row 35
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Hugsanlega þarf að meðh{\"o}ndla eða greina ástæðu hitans} \tn 
% Row Count 22 (+ 2)
% Row 36
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Lítil aukning í áhættu á að þróa með sér flogaveiki} \tn 
% Row Count 24 (+ 2)
% Row 37
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Kemur oft þegar hitinn er að hækka} \tn 
% Row Count 25 (+ 1)
% Row 38
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Flogaveiki}}\{\{ac\}\}} \tn 
% Row Count 26 (+ 1)
% Row 39
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Skilgreining 1}}} \tn 
% Row Count 27 (+ 1)
% Row 40
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Flogaveiki er sjúkdómur í miðtaugakerfi þar sem einstaklingur er í aukinni hættu á því að fá flog. }}} \tn 
% Row Count 30 (+ 3)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.14011 cm} x{2.83689 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Taugasjúkdómar barna (cont)}}  \tn
% Row 41
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Skilgreining 2}}} \tn 
% Row Count 1 (+ 1)
% Row 42
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Flogaveiki er samkvæmt skilgreiningu þegar það eru meira en 60 \% líkur á {\"o}ðru flogi innan 10 ára. }}} \tn 
% Row Count 4 (+ 3)
% Row 43
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Skilgreining 3}}} \tn 
% Row Count 5 (+ 1)
% Row 44
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{ Innan hugtaksins flogaveiki falla einnig þær afleyðingar sem enstaklingur getur hlotið af því að fá endurtekin flog.  }}} \tn 
% Row Count 8 (+ 3)
% Row 45
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Flogaheilkenni barna}}\{\{ac\}\}} \tn 
% Row Count 9 (+ 1)
% Row 46
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Mismunandi heilkenni floga hjá b{\"o}rnum á mismunandi aldri }}} \tn 
% Row Count 11 (+ 2)
% Row 47
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{1.Infantil spasm} \tn 
% Row Count 12 (+ 1)
% Row 48
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{2. Lenox Gastaut} \tn 
% Row Count 13 (+ 1)
% Row 49
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{3. St{\"o}ruflogaveiki} \tn 
% Row Count 14 (+ 1)
% Row 50
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{4. Panyatopolous flogaveiki} \tn 
% Row Count 15 (+ 1)
% Row 51
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{5. Góðkynja barnaflogaveiki} \tn 
% Row Count 16 (+ 1)
% Row 52
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{6. Juvenile Myoclon Epilepsy} \tn 
% Row Count 17 (+ 1)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{p{0.74655 cm} x{4.23045 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Flogaveiki barna}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Meðferð við flogaveiki hjá b{\"o}rnum}}: Heildræn nálgun\{\{ac\}\}} \tn 
% Row Count 2 (+ 2)
% Row 1
\SetRowColor{white}
{\bf{Lyf}} & Mikilvægt að velja lyf út frá gerð flogs, flogaheilkennis, aldurs og aukaverkunum \tn 
% Row Count 5 (+ 3)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Ekki {\"o}ll b{\"o}rn með flogaveiki þurfa lyf} \tn 
% Row Count 6 (+ 1)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Stundum þarf lyf sem st{\"o}ðvar flog} \tn 
% Row Count 7 (+ 1)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Lyfin hafa aukaverkanir} \tn 
% Row Count 8 (+ 1)
% Row 5
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Fræðsla}}} \tn 
% Row Count 9 (+ 1)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Fræða skóla og vini og aðstandendur} \tn 
% Row Count 10 (+ 1)
% Row 7
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Lífstíll}}} \tn 
% Row Count 11 (+ 1)
% Row 8
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Ræða bílpróf, þungun, áfengi, sund, klifur, hjálmanotkun og starfsval} \tn 
% Row Count 13 (+ 2)
% Row 9
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Meðferð}}} \tn 
% Row Count 14 (+ 1)
% Row 10
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Gjarnan hætt á meðferð ef bara eitt flog eftir 6 mán eða eftir 2 ár eftir greiningu flogaveiki en stundum ákveðið frá byrjun að það verði aldrei hætt} \tn 
% Row Count 18 (+ 4)
% Row 11
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Annað}}} \tn 
% Row Count 19 (+ 1)
% Row 12
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Ketogen diet, vagus nerv stimulator, skurðaðgerðir vegna flogaveiki} \tn 
% Row Count 21 (+ 2)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hreyfiraskanir}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Hreyfiraskanir}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Hvar er skaðinn sem orsakar hreyfitruflun?}}} \tn 
% Row Count 2 (+ 1)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Efri eða neðri hreyfitaug ? Taugav{\"o}ðvamót ? Sjúkdómur í v{\"o}ðvanum sjálfum ?} \tn 
% Row Count 4 (+ 2)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{**Cerebral palsy (heilal{\"o}mun) \{\{ac\}\}} \tn 
% Row Count 5 (+ 1)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Cerebral palsy (heilal{\"o}mun) er hópur sjúkdóma sem hafa áhrif á hreyfingu og samhæfingu hreyfinga. Ástæðan er skemmd á hreyfisvæðum heilans sem hefur átt sér stað áður en heilinn er full þroskaður, fyrir fæðingu, í fæðingu eða innan tveggja ára aldurs. }}} \tn 
% Row Count 11 (+ 6)
% Row 5
\SetRowColor{white}
Skimmed í heila: & Hreyfisvæði heila fyrir þroska \tn 
% Row Count 13 (+ 2)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Gerðir CP hreyfiskerðingar:}}} \tn 
% Row Count 14 (+ 1)
% Row 7
\SetRowColor{white}
Monoplegia & One limb- usually arm \tn 
% Row Count 16 (+ 2)
% Row 8
\SetRowColor{LightBackground}
Hemiplegia & One side of body \tn 
% Row Count 17 (+ 1)
% Row 9
\SetRowColor{white}
Quadriplegia & All four limbs \tn 
% Row Count 18 (+ 1)
% Row 10
\SetRowColor{LightBackground}
Diplegia & Both legs or arms \tn 
% Row Count 19 (+ 1)
% Row 11
\SetRowColor{white}
{\bf{T{\"o}lfræði}} & 1/400 b{\"o}rnum í UK \tn 
% Row Count 20 (+ 1)
% Row 12
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{3 megin týpur}}} \tn 
% Row Count 21 (+ 1)
% Row 13
\SetRowColor{white}
Spastísk - 80-90\% & Characterized by muscle stiffness and rigidity. \tn 
% Row Count 24 (+ 3)
% Row 14
\SetRowColor{LightBackground}
Dyskensísk & Involves involuntary, uncontrollable movements. \tn 
% Row Count 27 (+ 3)
% Row 15
\SetRowColor{white}
Ataxic & Associated with problems in balance and coordination. \tn 
% Row Count 30 (+ 3)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hreyfiraskanir (cont)}}  \tn
% Row 16
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Spinal muscular atrophy}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 17
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Spinal Muscular Atrophy (SMA) is a genetic neuromuscular disorder that primarily affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy.}}} \tn 
% Row Count 5 (+ 4)
% Row 18
\SetRowColor{LightBackground}
{\bf{Orsakir}} & Rýrnun í taugafrumum í fremra horni mænu. St{\"o}kkbreyting í SMN1 geni \tn 
% Row Count 9 (+ 4)
% Row 19
\SetRowColor{white}
{\bf{Merki}} & Barn sem grætur dauft, sýgur illa, merki um lágan v{\"o}ðvakraft við skoðun \tn 
% Row Count 13 (+ 4)
% Row 20
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Tegundir}}} \tn 
% Row Count 14 (+ 1)
% Row 21
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{SMA Type 1 (Werdnig-Hoffmann Disease):} \tn 
% Row Count 15 (+ 1)
% Row 22
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{This is the most severe form and usually manifests in the first few months of life. Infants with SMA Type 1 have profound muscle weakness, difficulty breathing, and a shortened life expectancy if not treated.}}} \tn 
% Row Count 20 (+ 5)
% Row 23
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{SMA Type 2:} \tn 
% Row Count 21 (+ 1)
% Row 24
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{ Typically, symptoms appear in infancy or early childhood. Children with Type 2 SMA can sit but may have difficulty walking and experience muscle weakness.}}} \tn 
% Row Count 25 (+ 4)
% Row 25
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{SMA Type 3 (Kugelberg-Welander Disease):} \tn 
% Row Count 26 (+ 1)
% Row 26
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{ Onset usually occurs in childhood or adolescence. Individuals with Type 3 SMA may have milder muscle weakness and are often able to walk but may face challenges with mobility.}}} \tn 
% Row Count 30 (+ 4)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hreyfiraskanir (cont)}}  \tn
% Row 27
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{SMA Type 4:} \tn 
% Row Count 1 (+ 1)
% Row 28
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{ This is the mildest form of the condition and can manifest in late childhood or adulthood. Muscle weakness in Type 4 SMA is generally less severe, and affected individuals can lead relatively normal lives.}}} \tn 
% Row Count 6 (+ 5)
% Row 29
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Duchenne, Becker og Limb Girdle myotonic dystrophy}}\{\{ac\}\}} \tn 
% Row Count 8 (+ 2)
% Row 30
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Genetic progressive l neuromuscular disorders sem tengjast X erfðum}}} \tn 
% Row Count 10 (+ 2)
% Row 31
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Algengustu v{\"o}ðvasjúkdómar barna (1/5000kk)} \tn 
% Row Count 11 (+ 1)
% Row 32
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Orsakir, merki meðferðir}}} \tn 
% Row Count 12 (+ 1)
% Row 33
\SetRowColor{LightBackground}
Ors{\"o}k & X tengdir genagallar.St{\"o}kkbreyting veldur skertri starfsemi dystrophin proteins í frumuhuimnu \tn 
% Row Count 17 (+ 5)
% Row 34
\SetRowColor{white}
Meðferð & Meðferð til við sumum tegundum st{\"o}kkbreytinga, t.d. stop codon- ataluren \tn 
% Row Count 21 (+ 4)
% Row 35
\SetRowColor{LightBackground}
Merki & Gowers sign \tn 
% Row Count 22 (+ 1)
% Row 36
\SetRowColor{white}
{\emph{Gowers' sign, also known as Gowers' maneuver or Gowers' method, is a characteristic movement pattern observed in children with muscle weakness, }} & Nota hendur til að hjálpa sér að setjast og standa \tn 
% Row Count 30 (+ 8)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hreyfiraskanir (cont)}}  \tn
% Row 37
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Dermatomyositis}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 38
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Dermatomyositis is a rare autoimmune inflammatory myopathy, which means it is a condition that affects the muscles and the skin. It is characterized by muscle weakness and skin rash. }}} \tn 
% Row Count 5 (+ 4)
% Row 39
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Merki}}} \tn 
% Row Count 6 (+ 1)
% Row 40
\SetRowColor{white}
Gowler's sign & Proximal muscle weakness of lower limbs \tn 
% Row Count 8 (+ 2)
% Row 41
\SetRowColor{LightBackground}
Gottorn papules & Papules yfir fingra liðum \tn 
% Row Count 10 (+ 2)
% Row 42
\SetRowColor{white}
Heliotrope rash & Rauð-fjólublátt útbrot á efri augnlokum \tn 
% Row Count 13 (+ 3)
% Row 43
\SetRowColor{LightBackground}
Nail fold changes & Capiliarry dilitations \tn 
% Row Count 15 (+ 2)
% Row 44
\SetRowColor{white}
{\bf{Meðferð}} & Glucocorticoids, cylcosporin, methotrexate \tn 
% Row Count 18 (+ 3)
% Row 45
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Bell's palsy}}\{\{ac\}\}} \tn 
% Row Count 19 (+ 1)
% Row 46
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{L{\"o}mun á n. Facialis sem er unilateral near hreyfitaugarl{\"o}mun og er ekki secunder}}\{\{ac\}\}} \tn 
% Row Count 21 (+ 2)
% Row 47
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Hvort er hún central eða perifer?} \tn 
% Row Count 22 (+ 1)
% Row 48
\SetRowColor{white}
{\bf{Meðferð}} & Lyf og augndropar \tn 
% Row Count 23 (+ 1)
% Row 49
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Meðferð inniheldur lyf; stera til að minnka bólgu og acyclovir. Talið vera post-infectious fyrirbæriAugað getur ekki lokast almennileg, jafnvel í svefn. Mikilvægt þess vegna að muna augndropa.} \tn 
% Row Count 28 (+ 5)
% Row 50
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Myasthenia Gravis}}\{\{ac\}\}} \tn 
% Row Count 29 (+ 1)
% Row 51
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Sjálfsónæmissjúkdómur - Óeðlileg v{\"o}ðvaþreyta við áreynslu sem lagast við hvíld eða lyfjameðferð (pyridostigmine sem eykur magn losun taugaboðefna á taugav{\"o}ðvamótum)}}} \tn 
% Row Count 33 (+ 4)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hreyfiraskanir (cont)}}  \tn
% Row 52
\SetRowColor{LightBackground}
{\bf{Pathophysiology}} & Mótefni gegn AChR á v{\"o}ðvafrumu. \tn 
% Row Count 2 (+ 2)
% Row 53
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{In MG, the immune system mistakenly produces antibodies against the acetylcholine receptors. These antibodies are usually directed against the nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction.} \tn 
% Row Count 7 (+ 5)
% Row 54
\SetRowColor{LightBackground}
The presence of AChR antibodies results in a functional impairment of the neuromuscular junction. Muscle weakness and fatigue occur because the nerve signals are not effectively transmitted to the muscle. & Truflun í taugav{\"o}ðvamótum \tn 
% Row Count 18 (+ 11)
% Row 55
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Einkenni}}} \tn 
% Row Count 19 (+ 1)
% Row 56
\SetRowColor{LightBackground}
Sveiflukennd einkenni & Starfsemi v{\"o}ðva versnar við endurtekið álag \tn 
% Row Count 22 (+ 3)
% Row 57
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{V{\"o}ðvaveikleiki} \tn 
% Row Count 23 (+ 1)
% Row 58
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Diplopia} \tn 
% Row Count 24 (+ 1)
% Row 59
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Ptosis} \tn 
% Row Count 25 (+ 1)
% Row 60
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Dysarthria} \tn 
% Row Count 26 (+ 1)
% Row 61
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Dysphagia} \tn 
% Row Count 27 (+ 1)
% Row 62
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Guillian- Barré heilkenni }}\{\{ac\}\}} \tn 
% Row Count 28 (+ 1)
% Row 63
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{(acute postinfectious polyneuropathy)\{\{ac\}\}} \tn 
% Row Count 29 (+ 1)
% Row 64
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{ Guillain-Barré syndrome (GBS) is a rare autoimmune disorder that affects the peripheral nervous system. It is characterized by the immune system's attack on the nerves, which can lead to muscle weakness, paralysis, and in severe cases, life-threatening complications. }}} \tn 
% Row Count 35 (+ 6)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hreyfiraskanir (cont)}}  \tn
% Row 65
\SetRowColor{LightBackground}
{\bf{Trigger}} & Post infection \tn 
% Row Count 1 (+ 1)
% Row 66
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Skammvinnur \seqsplit{sjálfsónæmissjúkdómur} sem kemur  2-3 vikum eftir efri loftvegaeinkenni} \tn 
% Row Count 3 (+ 2)
% Row 67
\SetRowColor{LightBackground}
{\bf{Autoimmune attack}} & Skemmdir í myelini taugafrumna\{\{nobreak\}\} \tn 
% Row Count 6 (+ 3)
% Row 68
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{GBS occurs when the body's immune system mistakenly targets and damages the myelin sheath (the protective covering) of peripheral nerves or, in some cases, the nerve cells themselves.}}} \tn 
% Row Count 10 (+ 4)
% Row 69
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Ascending Paralysis}}} \tn 
% Row Count 11 (+ 1)
% Row 70
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Einkenni byrja distalt og færast ofar, reflexar og v{\"o}ðvakraftur}}} \tn 
% Row Count 13 (+ 2)
% Row 71
\SetRowColor{LightBackground}
{\bf{Einkenni}} & V{\"o}ðval{\"o}mun, dysautonomia, miklir verkir \tn 
% Row Count 16 (+ 3)
% Row 72
\SetRowColor{white}
Dysautonomia & Hraður/hægur hjartsláttur, hár/lár blóðþrýstingur, þvagteppa, skert svitamyndun \tn 
% Row Count 21 (+ 5)
% Row 73
\SetRowColor{LightBackground}
{\bf{Útkoma}} & Mj{\"o}g mismunandi - flestir ná sér \tn 
% Row Count 23 (+ 2)
% Row 74
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Algengt er að versna I 3-4 vikur og er svo 2 vikur að ganga tilbaka að mestu en að því leyti sem hann gengur tilbaka innan 2 ára}}} \tn 
% Row Count 26 (+ 3)
% Row 75
\SetRowColor{LightBackground}
{\bf{Fylgikvillar}} & Öndunarbilun +Bilateral facial l{\"o}mun \tn 
% Row Count 28 (+ 2)
% Row 76
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Meðferð}}} \tn 
% Row Count 29 (+ 1)
% Row 77
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Þarf langa spítalainnl{\"o}gn og mótefnameðferð Flestir ná sér alveg (85\%)} \tn 
% Row Count 31 (+ 2)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{x{2.43873 cm} x{2.53827 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Heila- og taugasjúkdómar barna}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Stroke}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Heilablóðfall hjá b{\"o}rnum, eða heilablóðfall hjá b{\"o}rnum, getur verið með svipuð einkenni og hjá fullorðnum, svo sem skyndilegur máttleysi, samhæfingarleysi og tal{\"o}rðugleika. Hins vegar eru nokkur mikilvæg aðgreining sem þarf að hafa í huga:}}} \tn 
% Row Count 7 (+ 6)
% Row 2
\SetRowColor{LightBackground}
{\bf{Mismunagreining}} & Flog, mígreini, sýkingar \tn 
% Row Count 9 (+ 2)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{S{\"o}mu einkenni og hjá fullorðnum en margt hjá b{\"o}rnum líkist heilablóðfalli sem er ekki heilablóðfall} \tn 
% Row Count 12 (+ 3)
% Row 4
\SetRowColor{LightBackground}
{\bf{Uppvinnsla}} & Sama bráða meðferð + meiri uppvinnsla \tn 
% Row Count 15 (+ 3)
% Row 5
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Hjá b{\"o}rnum er {\"o}nnur uppvinnsla sem á sér stað á eftir heilablóðfallið til að finna ástæðuna og minnka líkur á endurtekningu. }}} \tn 
% Row Count 18 (+ 3)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Perinatal stroke }}} \tn 
% Row Count 19 (+ 1)
% Row 7
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Perinatal stroke algengt (1/2000 fæðingar) og þarf litla orsakauppvinnslu í kj{\"o}lfarið. Greinist oft seinna vegna floga eða CP.} \tn 
% Row Count 22 (+ 3)
% Row 8
\SetRowColor{LightBackground}
{\bf{Öryggi barns}} & Trauma \tn 
% Row Count 23 (+ 1)
% Row 9
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Muna við blæðingar og trauma ávalt að huga að velferð barns, er barnið í hættu fyrir endurteknum áverka?}}} \tn 
% Row Count 26 (+ 3)
% Row 10
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Microcephaly}}\{\{ac\}\}} \tn 
% Row Count 27 (+ 1)
% Row 11
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Microcephaly is a condition where a person has a smaller-than-average head size for their age and sex. It often indicates that the brain has not developed properly or has stopped growing, which can lead to intellectual and developmental disabilities.}}} \tn 
% Row Count 33 (+ 6)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.43873 cm} x{2.53827 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Heila- og taugasjúkdómar barna (cont)}}  \tn
% Row 12
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Macrocephaly}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 13
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{It refers to a condition where a person has a larger-than-average head size for their age and sex. Macrocephaly can be due to various causes, including benign enlargement of the subarachnoid spaces (hydrocephalus ex vacuo), benign familial macrocephaly, or more serious underlying conditions like hydrocephalus (excess cerebrospinal fluid in the brain), genetic syndromes, or other medical issues.}}} \tn 
% Row Count 9 (+ 8)
% Row 14
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Neural tube defects}}\{\{ac\}\}} \tn 
% Row Count 10 (+ 1)
% Row 15
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Neural tube defects (NTDs) are a group of congenital birth defects that involve incomplete development of the neural tube during early embryonic development. The neural tube is a structure that eventually develops into the brain and spinal cord. }}} \tn 
% Row Count 15 (+ 5)
% Row 16
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{ Spina Bifida}}} \tn 
% Row Count 16 (+ 1)
% Row 17
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Spina bifida can cause a range of physical and neurological problems, such as weakness or paralysis in the lower limbs, bladder and bowel dysfunction, and sometimes intellectual and learning disabilities.}}} \tn 
% Row Count 21 (+ 5)
% Row 18
\SetRowColor{LightBackground}
{\bf{Algengi}} & 2/1000 \tn 
% Row Count 22 (+ 1)
% Row 19
\SetRowColor{white}
{\bf{Folinsýra á meðg{\"o}ngu}} & Fyrstu gráðu ættingjar hærri skammt \tn 
% Row Count 24 (+ 2)
% Row 20
\SetRowColor{LightBackground}
{\bf{Taugakvillar}} & Truflun á starfsemi tauga í neðri útlimum Truflun á starfsemi tauga til þvagvega og endaþarms \tn 
% Row Count 29 (+ 5)
% Row 21
\SetRowColor{white}
{\bf{Fylgikvillar}} & Oft hydrocephalus \tn 
% Row Count 30 (+ 1)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.43873 cm} x{2.53827 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Heila- og taugasjúkdómar barna (cont)}}  \tn
% Row 22
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Hydrocephalus}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 23
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Hydrocephalus is a condition characterized by the accumulation of excess cerebrospinal fluid in the brain's ventricles, leading to increased intracranial pressure. }}} \tn 
% Row Count 5 (+ 4)
% Row 24
\SetRowColor{LightBackground}
{\bf{Algengi}} & 85/100 000 \tn 
% Row Count 6 (+ 1)
% Row 25
\SetRowColor{white}
{\bf{Einkenni}} & Ógleði, uppk{\"o}st og h{\"o}fuðverkur meiri á morgnanna \tn 
% Row Count 9 (+ 3)
% Row 26
\SetRowColor{LightBackground}
{\bf{Aukið h{\"o}fuðummál}} & Hjá yngstu b{\"o}rnum \tn 
% Row Count 11 (+ 2)
% Row 27
\SetRowColor{white}
{\bf{Óeðlilegt g{\"o}ngulag}} & Breiðspora g{\"o}ngulag \tn 
% Row Count 13 (+ 2)
% Row 28
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Hydrocephalus can affect coordination and muscle control, resulting in a wide-based gait (abnormal walking pattern).} \tn 
% Row Count 16 (+ 3)
% Row 29
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Sjónskerðing}}} \tn 
% Row Count 17 (+ 1)
% Row 30
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{: Increased intracranial pressure can lead to visual disturbances or visual impairment.} \tn 
% Row Count 19 (+ 2)
% Row 31
\SetRowColor{white}
{\bf{Meðferð}} & Lyfjameðferð + aðgerð \tn 
% Row Count 21 (+ 2)
% Row 32
\SetRowColor{LightBackground}
T{\"o}flumeðferð: & Acetazolamíð, þvagræsilyf, flogalyf \tn 
% Row Count 23 (+ 2)
% Row 33
\SetRowColor{white}
Aðgerð & Aðgerð, periventricular shunt sem leiðir v{\"o}kva frá v{\"o}kvarýmum í h{\"o}fði að kviðarholi, háð ákveðnum þrýstingi sem hægt er að stilla \tn 
% Row Count 31 (+ 8)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.43873 cm} x{2.53827 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Heila- og taugasjúkdómar barna (cont)}}  \tn
% Row 34
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{ Neurofibromatosis}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 35
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{ Neurofibromatosis (NF) is a group of genetic disorders that primarily affect the nervous system and can lead to the formation of tumors on nerves throughout the body.}}} \tn 
% Row Count 5 (+ 4)
% Row 36
\SetRowColor{LightBackground}
{\bf{Uppruni í fósturþroska}} & Ectoderm- 	sami fósturfræðilegi uppruni (húð-taugakerfi) \tn 
% Row Count 9 (+ 4)
% Row 37
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{NF is a group of genetic disorders that affect the nervous system and have their origin in the ectodermal layer during embryonic development. This layer gives rise to structures like the skin and the nervous system.}}} \tn 
% Row Count 14 (+ 5)
% Row 38
\SetRowColor{LightBackground}
{\bf{Algengi}} & 1/3000 \tn 
% Row Count 15 (+ 1)
% Row 39
\SetRowColor{white}
{\bf{Orsakir}} & St{\"o}kkbreyting á litningi 17 \tn 
% Row Count 17 (+ 2)
% Row 40
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Áhrif}}} \tn 
% Row Count 18 (+ 1)
% Row 41
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Lítil áhrif á lifun og greind} \tn 
% Row Count 19 (+ 1)
% Row 42
\SetRowColor{LightBackground}
Hnútar myndast í slíðri taugafrumna & bæði innan og utan miðtaugakerfis \tn 
% Row Count 22 (+ 3)
% Row 43
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Tuberous sclerosis}}\{\{ac\}\}} \tn 
% Row Count 23 (+ 1)
% Row 44
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Tuberous sclerosis, also known as tuberous sclerosis complex (TSC), is a rare genetic disorder that can affect multiple organ systems. }}} \tn 
% Row Count 26 (+ 3)
% Row 45
\SetRowColor{white}
{\bf{Algengi}} & 1/9000 \tn 
% Row Count 27 (+ 1)
% Row 46
\SetRowColor{LightBackground}
{\bf{Einkenni}} & M{\"o}rg líffærakerfi en sérst{\"o}k tegund útbrota í húð \tn 
% Row Count 30 (+ 3)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.43873 cm} x{2.53827 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Heila- og taugasjúkdómar barna (cont)}}  \tn
% Row 47
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Ash leaf, facial angiofibroma}}} \tn 
% Row Count 1 (+ 1)
% Row 48
\SetRowColor{white}
{\bf{Orsakir}} & Genagalli \tn 
% Row Count 2 (+ 1)
% Row 49
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{St{\"o}kkbreyting í litningi 9, TSC1 og 2 gen. Autosomal dominant með variable penetrance} \tn 
% Row Count 4 (+ 2)
% Row 50
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Fylgieinkenni}}} \tn 
% Row Count 5 (+ 1)
% Row 51
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Stundum tumorar í h{\"o}fði og hjarta} \tn 
% Row Count 6 (+ 1)
% Row 52
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Flogaveiki – infantile spasm} \tn 
% Row Count 7 (+ 1)
% Row 53
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Taugahr{\"o}rnunarsjúkdómar}}} \tn 
% Row Count 8 (+ 1)
% Row 54
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Nieman Picks, Juvenile Huntingtons, Krabbe, Retts, MPS, Friedrichs ataxia, Wilsons, Alpers og Tay Sachs, NCL (neuronal lipofuscinosis)}}} \tn 
% Row Count 11 (+ 3)
% Row 55
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Valda áframhaldandi skemmdum á taugum-{}-{}- Misalvarlegir en flestir alvarlegir} \tn 
% Row Count 13 (+ 2)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{x{2.43873 cm} x{2.53827 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Take home skilaboð}}  \tn
% Row 0
\SetRowColor{LightBackground}
{\bf{Flog og h{\"o}fuðverkir hjá b{\"o}rnum}} & ekki merki um krabbamein í h{\"o}fði (oftast) \tn 
% Row Count 3 (+ 3)
% Row 1
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{ Seizures and headaches in children are not necessarily indicative of head cancer. In most cases, there are other, less serious causes. Proper evaluation by healthcare professionals is essential to determine the underlying cause and provide appropriate care.}}} \tn 
% Row Count 9 (+ 6)
% Row 2
\SetRowColor{LightBackground}
{\bf{Krampar með hita}} & Eru ekki endilega með alvarlegan sjúkdóm (hitakrampar) \tn 
% Row Count 12 (+ 3)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{: Some children experience convulsions when they have a fever, known as febrile convulsions. These are often benign and associated with fever, without necessarily indicating a serious illness.}}} \tn 
% Row Count 16 (+ 4)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Til eru heilkenni floga hjá b{\"o}rnum }}} \tn 
% Row Count 17 (+ 1)
% Row 5
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{There are various seizure syndromes specific to children, each with its own characteristics and prognosis. Accurate diagnosis and appropriate management are crucial.} \tn 
% Row Count 21 (+ 4)
% Row 6
\SetRowColor{LightBackground}
B{\"o}rn fá líka heilablóðfall, & greining og orsakauppvinnsla ólík en meðferð svipuð \tn 
% Row Count 24 (+ 3)
% Row 7
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Miklar framfarir á sviði genalækninga og lækninga við sjaldgæfum sjúkdómum má vænta á næstu árum} \tn 
% Row Count 27 (+ 3)
% Row 8
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Í meðferð taugasjúkdóma hjá b{\"o}rnum er heildræn fj{\"o}lskyldumiðuð teymismeðferð mikilvæg} \tn 
% Row Count 29 (+ 2)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{'}  \tn 
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}


% That's all folks
\end{multicols*}

\end{document}